NCT00474864View on ClinicalTrials.gov

Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia.

PHASE2CompletedINTERVENTIONAL

Enrollment

66

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions

Healthy SubjectsDyslipidaemiasDyslipidaemia

Interventions

DRUG

GW856553

Trial Locations (3)

EC1M 6BQ

GSK Investigational Site, London

CB2 2GG

GSK Investigational Site, Cambridge

CF144XW

GSK Investigational Site, Cardiff

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY